Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial
- PDF / 1,400,075 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 71 Downloads / 161 Views
RESEARCH
Open Access
Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial Kuat Oshakbayev1* , Bibazhar Dukenbayeva2, Gulnar Togizbayeva3, Aigul Durmanova4, Meruyert Gazaliyeva5, Abdul Sabir6, Aliya Issa7 and Alisher Idrisov8
Abstract Background: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10–21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes. Trial registration: ClinicalTrials.gov Identifier: NCT02503865. Retrospectively registered November 2015. Keywords: Type 2 diabetes, Weight loss, Restriction diet, Glycemic/lipid and hormone profiles, Lipid/protein oxidation
* Correspondence: [email protected] 1 Metabolic Syndrome Department, Nazarbayev University Medical Center, Street Baitursynuly, 5, fl. 601, 010000 Astana, Kazakhstan Full list of author information is available at the end of the article © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative
Data Loading...